National Health Investors (NYSE:NHI) Hits New 1-Year Low on Analyst Downgrade

Key Points

• National Health Investors fell to a new 52-week low after Bank of America downgraded the stock from Buy to Underperform and cut its price target from $86 to $67. Shares traded as low as $63.31.
• Analyst views remain mixed: despite the downgrade and other rating cuts, the consensus rating is “Moderate Buy,” with an average price target of $79.44.
• The REIT declared a quarterly dividend of $0.92 per share, equivalent to $3.68 annually and a yield of about 5.8% at the reported share price.

National Health Investors, Inc. (NYSE:NHI - Get Free Report)'s stock price reached a new 52-week low on Friday after Bank of America downgraded the stock from a buy rating to an underperform rating. Bank of America now has a $67.00 price target on the stock, down from their previous price target of $86.00. National Health Investors traded as low as $63.31 and last traded at $63.53, with a volume of 16,587 shares. The stock had previously closed at $64.55.

Several other equities research analysts have also recently issued reports on NHI. Weiss Ratings cut shares of National Health Investors from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Friday, September 25th. Zacks Research upgraded shares of National Health Investors from a "strong sell" rating to a "hold" rating in a research report on Tuesday, September 29th. Wells Fargo & Company dropped their price target on National Health Investors from $78.00 to $68.00 and set an "equal weight" rating on the stock in a research report on Monday, October 19th. National Bank Financial set a $79.00 price objective on shares of National Health Investors in a research report on Wednesday, September 9th. Finally, BMO Capital Markets reaffirmed an "outperform" rating on shares of National Health Investors in a report on Wednesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $79.44.

More National Health Investors News

These are some of the NHI news items that stood out recently:

• Positive Sentiment: Huntington maintained a “Strong-Buy” rating and projected EPS growth from $4.76 in FY2026 to $5.00 in FY2027 and $5.27 in FY2028. Its quarterly forecasts also show a gradual rise, suggesting improving earnings expectations. Huntington estimates
• Neutral Sentiment: A Zacks article compared NHI with RLJ Lodging as a potential value investment but the provided summary does not state which stock it favors, so it offers no clear directional signal for NHI. Zacks comparison
• Negative Sentiment: Bank of America downgraded NHI from “Buy” to “Underperform” and cut its price target to $67 from $86. The new target implies only about 3.6% upside from $64.67, signaling reduced confidence and potentially weighing on the shares. Tickerreport coverage

Institutional Trading of National Health Investors

Several institutional investors have recently made changes to their positions in the stock. BlackRock Inc. acquired a new position in National Health Investors during the second quarter valued at approximately $665,997,000. Principal Financial Group Inc. grew its stake in National Health Investors by 2.0% in the first quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust's stock worth $137,537,000 after purchasing an additional 32,902 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in shares of National Health Investors in the 2nd quarter worth approximately $122,509,000. Bank of America Corp DE boosted its holdings in National Health Investors by 20.0% in the first quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust's stock worth $80,278,000 after purchasing an additional 165,467 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of National Health Investors by 2.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 686,249 shares of the real estate investment trust's stock valued at $55,493,000 after buying an additional 18,164 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Stock Performance

The company has a market capitalization of $3.12 billion, a price-to-earnings ratio of 4.46, a P/E/G ratio of 4.21 and a beta of 0.51. The stock has a 50 day simple moving average of $67.48 and a 200 day simple moving average of $75.93. The company has a quick ratio of 6.78, a current ratio of 13.59 and a debt-to-equity ratio of 0.50.

National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, topping the consensus estimate of $1.18 by $10.29. National Health Investors had a return on equity of 41.41% and a net margin of 152.82%. The firm had revenue of $113.48 million for the quarter, compared to analyst estimates of $68.53 million. As a group, analysts anticipate that National Health Investors, Inc. will post 4.76 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date of this dividend is Thursday, December 31st. National Health Investors's dividend payout ratio is 26.40%.

National Health Investors Company Profile

National Health Investors, Inc. NYSE: NHI is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI's portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.